Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Avasopasem Manganese
2. Gc4419
1. Ey1wa413ul
2. Avasopasem Manganese [usan]
3. Gc4419
4. Sc-72325a
5. M-40419
6. Unii-ey1wa413ul
7. Avasopasem Manganese Dichloride
8. Avasopasem Manganese [inn]
9. Avasopasem Manganese [who-dd]
10. Gc-4419
11. (pbpy-7-11-2344'3')-dichloro((4as,13as,17as,21as)-1,2,3,4,4a,5,6,12,13,13a,14,15,16,17,17a,18,19,20,21,21a-icosahydro-7,11-azeno-7h-dibenzo(b,h)(1,4,7,10)tetraazacycloheptadecine-.kappa.5n5,n13,n18,n21,n22)manganese
12. Manganese, Dichloro((4as,13as,17as,21as)-1,2,3,4,4a,5,6,12,13,13a,14,15,16,17,17a,18,19,20,21,21a-eicosahydro-7,11-nitrilo-7h-dibenzo(b,h)-5,13,18,21-tetraazacycloheptadecine-.kappa.n5,.kappa.n13,.kappa.n18,.kappa.n21,.kappa.n22)-, (pb-7-11-2344'3')-
Molecular Weight | 483.4 g/mol |
---|---|
Molecular Formula | C21H35Cl2MnN5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 0 |
Exact Mass | 482.164995 g/mol |
Monoisotopic Mass | 482.164995 g/mol |
Topological Polar Surface Area | 61 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 381 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Free Radical Scavengers
Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)
Avasopasem manganese is a superoxide dismutase mimetic that rapidly and selectively converts superoxide to hydrogen peroxide and oxygen in order to protect normal tissue from radiation therapy-induced damage. This drug is currently being investigated against oral mucositis, esophagitis, and COVID-19.
ABOUT THIS PAGE
61
PharmaCompass offers a list of Avasopasem manganese API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Avasopasem manganese manufacturer or Avasopasem manganese supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Avasopasem manganese manufacturer or Avasopasem manganese supplier.
PharmaCompass also assists you with knowing the Avasopasem manganese API Price utilized in the formulation of products. Avasopasem manganese API Price is not always fixed or binding as the Avasopasem manganese Price is obtained through a variety of data sources. The Avasopasem manganese Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Avasopasem manganese manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Avasopasem manganese, including repackagers and relabelers. The FDA regulates Avasopasem manganese manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Avasopasem manganese API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Avasopasem manganese supplier is an individual or a company that provides Avasopasem manganese active pharmaceutical ingredient (API) or Avasopasem manganese finished formulations upon request. The Avasopasem manganese suppliers may include Avasopasem manganese API manufacturers, exporters, distributors and traders.
Avasopasem manganese Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Avasopasem manganese GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Avasopasem manganese GMP manufacturer or Avasopasem manganese GMP API supplier for your needs.
A Avasopasem manganese CoA (Certificate of Analysis) is a formal document that attests to Avasopasem manganese's compliance with Avasopasem manganese specifications and serves as a tool for batch-level quality control.
Avasopasem manganese CoA mostly includes findings from lab analyses of a specific batch. For each Avasopasem manganese CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Avasopasem manganese may be tested according to a variety of international standards, such as European Pharmacopoeia (Avasopasem manganese EP), Avasopasem manganese JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Avasopasem manganese USP).